Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma

医学 安慰剂 临床终点 短尾鱼 内科学 脊索瘤 危险系数 胃肠病学 肿瘤科 置信区间 随机对照试验 免疫学 外科 病理 生物 胚胎干细胞 基因 替代医学 中胚层 生物化学
作者
Peter J. DeMaria,Marijo Bilušić,Deric M. Park,Christopher R. Heery,Renee N. Donahue,Ravi A. Madan,Mohammad Hadi Bagheri,Julius Strauss,Victoria Shen,Jennifer L. Marté,Seth M. Steinberg,Jeffrey Schlom,Mark R. Gilbert,James L. Gulley
出处
期刊:Oncologist [AlphaMed Press]
卷期号:26 (5): e847-e858 被引量:37
标识
DOI:10.1002/onco.13720
摘要

Brachyury is a transcription factor overexpressed in chordoma and is associated with chemotherapy resistance and epithelial-to-mesenchymal transition. GI-6301 is a recombinant, heat-killed Saccharomyces cerevisiae yeast-based vaccine targeting brachyury. A previous phase I trial of GI-6301 demonstrated a signal of clinical activity in chordomas. This trial evaluated synergistic effects of GI-6301 vaccine plus radiation.Adults with locally advanced, unresectable chordoma were treated on a randomized, placebo-controlled trial. Patients received three doses of GI-6301 (80 × 107 yeast cells) or placebo followed by radiation, followed by continued vaccine or placebo until progression. Primary endpoint was overall response rate, defined as a complete response (CR) or partial response (PR) in the irradiated tumor site at 24 months. Immune assays were conducted to evaluate immunogenicity.Between May 2015 and September 2019, 24 patients enrolled on the first randomized phase II study in chordoma. There was one PR in each arm; no CRs were observed. Median progressive-free survival for vaccine and placebo arms was 20.6 months (95% confidence interval [CI], 5.7-37.5 months) and 25.9 months (95% CI, 9.2-30.8 months), respectively. Hazard ratio was 1.02 (95% CI, 0.38-2.71). Vaccine was well tolerated with no vaccine-related serious adverse events. Preexisting brachyury-specific T cells were detected in most patients in both arms. Most patients developed T-cell responses during therapy, with no difference between arms in frequency or magnitude of response.No difference in overall response rate was observed, leading to early discontinuation of this trial due to low conditional power to detect statistical difference at the planned end of accrual.Chordoma is a rare neoplasm lacking effective systemic therapies for advanced, unresectable disease. Lack of clinically actionable somatic mutations in chordoma makes development of targeted therapy quite challenging. While the combination of yeast-brachyury vaccine (GI-6301) and standard radiation therapy did not demonstrate synergistic antitumor effects, brachyury still remains a good target for developmental therapeutics in chordoma. Patients and their oncologists should consider early referral to centers with expertise in chordoma (or sarcoma) and encourage participation in clinical trials.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
感性的酬海完成签到,获得积分10
1秒前
王王的狗子完成签到 ,获得积分10
1秒前
innyjiang完成签到,获得积分10
3秒前
陆王牛马完成签到 ,获得积分10
4秒前
4秒前
Ava应助念念采纳,获得10
5秒前
LIAO完成签到,获得积分10
5秒前
迅速凝竹完成签到 ,获得积分10
7秒前
妮妮完成签到,获得积分10
8秒前
8秒前
哈哈哈完成签到,获得积分20
9秒前
快乐随心完成签到 ,获得积分10
10秒前
了一李完成签到 ,获得积分10
10秒前
fqk完成签到,获得积分10
10秒前
活泼新儿完成签到,获得积分10
10秒前
11秒前
老迟到的羊完成签到 ,获得积分10
11秒前
可爱的函函应助sl采纳,获得30
15秒前
CatC完成签到,获得积分10
15秒前
LIKO完成签到,获得积分10
15秒前
15秒前
15秒前
David发布了新的文献求助10
16秒前
16秒前
clock完成签到 ,获得积分10
16秒前
风中小懒虫完成签到,获得积分10
17秒前
cindy完成签到 ,获得积分10
18秒前
Tysonqu完成签到,获得积分10
18秒前
科研通AI2S应助Promise采纳,获得10
19秒前
20秒前
淡淡阁完成签到 ,获得积分10
20秒前
念念发布了新的文献求助10
20秒前
漂亮的秋天完成签到 ,获得积分10
22秒前
David完成签到,获得积分10
22秒前
Jason完成签到,获得积分10
22秒前
26秒前
27秒前
27秒前
YY完成签到,获得积分10
28秒前
调皮的凝旋完成签到,获得积分10
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029